How Ph.D. was paid
$895,410 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Other | Total |
|---|---|---|---|---|
| A. Rachel Leheny, Ph.D.Chief Executive Officer | $427,350 | $464,485 | $3,575 | $895,410 |
| Sudarshan Hebbar, M.D.Chief Medical Officer | $427,350 | $332,486 | $3,478 | $763,315 |
| Eric W. RobertsVice Chairman and Chief Business Officer | $400,525 | $299,721 | $3,311 | $703,558 |
What changed and why
- $895K2025 CEO total compensation was $895,410, down from $1,657,842 in 2024.
- $464K2025 CEO compensation included $464,485 in option awards and $427,350 in salary.
- 2025 bonuses and non-equity incentive compensation were shown as dashes for all three named executives.
- April 2025 option grants were determined using peer data from the compensation consultant.
- 2025 stock options generally vest over four years and may accelerate upon certain termination or change-in-control events.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.